Titan Medical (TMDIF) Competitors

Pro-Dex (NASDAQ:PDEX) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their community ranking, analyst recommendations, dividends, media sentiment, profitability, valuation, earnings, institutional ownership and risk.

Does the MarketBeat Community believe in PDEX or TMDIF?

Pro-Dex received 155 more outperform votes than Titan Medical when rated by MarketBeat users.

Company	Underperform	Outperform
Pro-Dex	Outperform Votes 155 61.75%	Underperform Votes 96 38.25%
Titan Medical	N/A	N/A

Which has more risk and volatility, PDEX or TMDIF?

Pro-Dex has a beta of 0.4, suggesting that its stock price is 60% less volatile than the S&P 500. Comparatively, Titan Medical has a beta of 1.26, suggesting that its stock price is 26% more volatile than the S&P 500.

Do insiders and institutionals have more ownership in PDEX or TMDIF?

15.3% of Pro-Dex shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 47.5% of Pro-Dex shares are owned by insiders. Comparatively, 0.0% of Titan Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Is PDEX or TMDIF more profitable?

Pro-Dex has a net margin of 11.06% compared to Titan Medical's net margin of 0.00%. Pro-Dex's return on equity of 21.68% beat Titan Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pro-Dex	11.06%	21.68%	12.40%
Titan Medical	N/A	-82.31%	-51.47%

Which has better earnings and valuation, PDEX or TMDIF?

Titan Medical has lower revenue, but higher earnings than Pro-Dex. Titan Medical is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pro-Dex	$61.00M	3.25	$2.13M	$2.01	30.26
Titan Medical	$17.63M	2.31	$6.95M	$0.05	7.15

Do analysts rate PDEX or TMDIF?

Pro-Dex currently has a consensus target price of $52.00, suggesting a potential downside of 14.52%. Given Pro-Dex's stronger consensus rating and higher possible upside, analysts clearly believe Pro-Dex is more favorable than Titan Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pro-Dex	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Does the media refer more to PDEX or TMDIF?

In the previous week, Pro-Dex had 6 more articles in the media than Titan Medical. MarketBeat recorded 6 mentions for Pro-Dex and 0 mentions for Titan Medical. Pro-Dex's average media sentiment score of 1.31 beat Titan Medical's score of 0.00 indicating that Pro-Dex is being referred to more favorably in the media.

Company	Overall Sentiment
Pro-Dex	Positive
Titan Medical	Neutral

Summary

Pro-Dex beats Titan Medical on 15 of the 17 factors compared between the two stocks.